Recreational stimulant use is a growing concern among young adults, with 4.4% and 5% to 35% of college students endorsing cocaine (1) and recreational amphetamine (methylphenidate, dextroamphetamine) (2) use, respectively, and 16% of cocaine experimenters developing dependence within 10 years (3). To develop cost-effective prevention and intervention strategies, it is crucial to identify ultra-high risk recreational users. However, little is known about biobehavioral markers forecasting trajectory of occasional stimulant use to stimulant use disorder (SUD). Previous stimulant use research is predominantly cross-sectional, comparing individuals with chronic stimulant use with healthy individuals; although findings from these studies highlight brain disruptions related to drug use, they cannot disentangle whether disruptions preceded or were a result of chronic use.
Young adulthood is a period of increased independence, often providing more opportunities for risky behavior such as drug experimentation. Risky behavior can be defined as actions that may be subjectively desirable but are potentially harmful (4) and is typically quantified in young adults by their degree of substance use, unprotected sex, health habits, and crime engagement (5) . Risk taking often occurs in clusters of maladaptive behaviors, suggesting underlying impairments in decision making (6) (7) (8) .
Decision making involves several brain processes, including learning, inhibition, and outcome assessment, specifically appraising positive (i.e., safety or reward) or negative (i.e., risk or punishment) valence of choices (9, 10) . Functional magnetic resonance imaging (fMRI) research indicates that individuals with SUD show impaired decision making associated with altered brain activation in executive control and reward processing regions (11) (12) (13) (14) (15) . Decision making is thought to involve a cooperative relationship between an impulsive system activated by immediate rewards and an inhibitory control system. Through learning, the control network allows individuals to resist immediate attraction to rewards in favor of longer-term advantageous outcomes (16) . In SUD, biobehavioral indices of risk taking suggest an underlying imbalance between the control and impulsive systems.
The control system integral to decision making comprises prefrontal cortex (PFC), theorized as responsible for learning the relationship between stimuli and outcome, working memory, and inhibiting behavior (17) . SUD samples exhibit frontal lobe impairments associated with compromised decision making and increased risk behavior (17) . For example, cocaine abusers exhibit dorsolateral PFC (DLPFC) hypoactivation during response inhibition (18) and prediction of uncertain outcomes (19) ; in cocaine dependence, orbitofrontal cortex and DLPFC attenuation are linked to reduced ability to differentiate between variable monetary gains (20) . Similarly, methamphetamine users inaccurately process success or failure of available options, a pattern associated with orbitofrontal cortex/DLPFC hypoactivation (21) .
Working in conjunction with frontal regions is striatum, an area associated with reward processing (22) , selecting and initiating actions (23) , and learning (24) . During the Iowa Gambling Task (25) , healthy individuals show stronger striatal activation to wins than to losses (26, 27) , but amphetaminedependent individuals demonstrate hypersensitive striatal responses to rewards (28) . Cocaine and methamphetamine users also exhibit striatal hyperactivation but frontal hypoactivation during risky decision-making tasks such as the Iowa Gambling Task and the Balloon Analogue Risk Task (29) that is linked to riskier behavioral performance (13, 28, 30) . This suggests that such neural patterns during decision making promote favoring of risky incentives (28) .
Evidence from fMRI studies has led researchers to theorize that frontal lobe and striatum form a functional circuit with insular cortex and anterior cingulate cortex (ACC); these regions coordinate to integrate emotional and autonomic information about rewards into goal-oriented behavior (31, 32) . ACC is proposed to be involved in emotion and behavior management based on its neural connections to both the emotion processing limbic system and the cognitive control center, PFC (33) . Insula is proposed to play a role in interoceptive processing, wherein individuals integrate physiological cues to differentiate between risky and safe decisions and transform these cues into conscious feelings and behaviors (32) . ACC and insula hypoactivation is evident in chronic stimulant users in response inhibition and error monitoring during decision making (34) (35) (36) . Evidence for aberrant activity in key components of the PFC-limbic network has led researchers to suggest that weakened ability to accurately process information about options and control behaviors leads to favoring choices that offer immediate, rather than delayed, rewards (37) .
Cross-sectional studies of occasional stimulant users (OSUs) report decision-making impairments that parallel findings in stimulant-dependent individuals, including 1) weakened inhibitory control and reduced cognitive flexibility (38,39); 2) neuropsychological impairments in executive functions (e.g., attention, set shifting) (40, 41) ; and 3) frontal, striatal, and insular attenuation during a Risky Gains Task (RGT) paired with reduced ability to differentiate between safe and risky decisions (42).
Several research groups have recognized limitations of cross-sectional addiction research and have shifted toward a longitudinal approach to understand the transition to problematic substance use (43) (44) (45) . Structural MRI studies show that decreased brain volume in frontocentral regions at age 14 years predicts binge drinking at age 16 (46) and that frontostriatal regions are linked to heightened stimulant use in OSUs 1 to 2 years later (45) . However, fMRI has been less applied to predict the development of SUD.
The current longitudinal study used follow-up clinical and drug use data from OSUs (n = 144) 3 years after an fMRI scan (42) to determine whether baseline behavioral and blood oxygen level-dependent (BOLD) responses during the RGT 1) differentiated young adults who became problem stimulant users (PSUs; n = 35) from those who desisted from stimulant use (desisted stimulant users [DSUs] ; n = 75) during the 3-year interim (categorical approach) and 2) predicted cumulative baseline and follow-up stimulant and marijuana use across OSUs, regardless of clinical status (dimensional approach; n = 144), to address concerns regarding significant rates of marijuana and stimulant co-use (47) . Analyses compared BOLD activity related to specific task requirements: decision contrasts compared BOLD activity during risk-taking choice trials versus safe choice trials; outcome contrasts compared BOLD activity on trials where each subject took a risk and subsequently earned a win or a loss.
Categorical hypotheses were tested based on prior biobehavioral findings in stimulant-dependent individuals: 1) PSUs would exhibit riskier task performance than DSUs; 2) PSUs would show greater striatal BOLD signals than DSUs to outcomes, particularly in response to risky wins; and 3) PSUs would exhibit lower PFC, insular, and cingulate BOLD signals during decision making. Because dimensional analyses were exploratory, no a priori hypotheses were tested.
METHODS AND MATERIALS

Participants
The University of California, San Diego, Human Subjects Review Board approved the study protocol. Participants were recruited through newspapers, internet ads, and fliers mailed to college students. Figure 1 demonstrates participant recruitment and categorical/dimensional data analysis protocol. A total of 1025 individuals were phone screened, and 184 OSUs meeting study criteria provided written informed consent to participate. OSU inclusionary criteria were as follows: 1) within the last 6 months, two or more separate occasions of cocaine or prescription amphetamine use (e.g., methylphenidate, dextroamphetamine) without a prescribed purpose; 2) no lifetime stimulant dependence; 3) no lifetime stimulant use for medical reasons; and 4) no drug treatment interest. Participants completed three sessions: 1) a baseline diagnostic interview to determine lifetime psychiatric diagnoses and current drug use patterns (n = 184), 2) a neuroimaging session completing the RGT (n = 161), and 3) a follow-up interview session 3 years later to determine changes in drug use and clinical diagnoses (n = 144). The current study includes data from OSUs who completed all three sessions (n = 144). No OSU reported using methamphetamines at baseline; Frontostriatal Signals Predict Stimulant Use all baseline stimulant use was of cocaine and prescription stimulants.
Baseline Session
Participants were screened for lifetime DSM-IV Axis I diagnoses (including attention-deficit/hyperactivity disorder and substance abuse/dependence) and Axis II antisocial personality disorder by the Semi-Structured Assessment for the Genetics of Alcoholism II (48) and were administered the Wechsler Test of Adult Reading, a verbal intelligence measure (IQ) (49) . Exclusion criteria are outlined in Stewart et al. (50) and are included in the Supplement. Subjects completed a baseline urine toxicology screen and were excluded if they tested positive for stimulants (thereby avoiding confounding effects from recent use). Testing positive for cannabis was not exclusionary because its presence in urine may last up to 6 weeks.
Risky Gains Task
The RGT (illustrated in Figure 2 ) has been previously described by our experimental group (42, (51) (52) (53) (54) . On each trial, participants were shown the numbers 20, 40, and 80 in increasing order, which represented the number of cents to be added to their total. Participants were informed that 20 was always the "safe option" but that they had the option to wait 1 second to receive 40 cents or to wait an additional second to receive 80 cents. They were also informed of the potential that 40 or 80 would appear in red font, denoting actual losses of money (240 or 280) from the total score, with 40 and 80 being explicitly called "risky options." Unknown to subjects, 240 and 280 outcome frequencies were predefined so that the final gain was identical regardless of whether they selected 20, 40, or 80 cents. That is, there was no actual advantage to selecting risky options compared with safe options. Participants were told that a positive value needed to be collected via an index finger button press within a subsequent 1-second window. A press outside of that timeframe would result in a loss. The 1-second length was chosen to allow slow-responding individuals to collect an option. Auditory and visual feedback ("yay"/"You win" for wins and "yuck"/"You lose" for losses) followed each choice. Cumulative total (in dollars) was displayed after trial completion to allow performance monitoring. The task consisted of 96 trials lasting 3.5 seconds each. Three trial types were presented in a preset randomized order: 54 rewarded (120, 140, 180) trials, 24 punished 240 trials, and 18 punished 280 trials. In addition to potential losses due to slow responses or nonresponses on rewarded trials, the RGT design led to each participant , 172 sagittally acquired slices, .97 3 .97 3 1 mm 3 voxels) was also obtained as a reference.
Three-Year Follow-Up Interview
OSUs participated in another standardized interview 3 years after their baseline sessions (Figure 1) , by phone or in-person, to assess drug use severity during the interim period. Analyses were conducted using both categorical and dimensional definitions of interim stimulant use as recommended by Rabin and Moeller (58) . For categorical analyses, participants were grouped into one of two categories: PSUs or DSUs. PSUs (n = 35) were a priori defined based on the current DSM-5 criteria for SUD (59): 1) continued stimulant use since baseline and 2) endorsement of two or more DSM-IV symptoms of stimulant abuse or dependence occurring together for 6 or more consecutive interim months. Among PSUs, 51% met criteria for cocaine abuse, 23% met criteria for cocaine dependence, 46% met criteria for amphetamine abuse, and 17% met criteria for amphetamine dependence. DSUs (n = 75) were defined based on the emphasis of the choice to desist as a critical part of addiction recovery models (60) and in the prevention of transition to SUD (61): 1) no 6-month periods of three or more stimulant uses and 2) no endorsement of interim SUD symptoms. OSUs who did not meet criteria for either PSU or DSU (n = 34) were excluded from categorical analyses because of the highly variable nature of those who did not fit either category (e.g., met only one abuse/dependence criterion, used too many times during interim but no accompanying symptoms). Dimensional analyses were conducted using all OSUs (n=144), where RGT BOLD signals were correlated with baseline and interim stimulant and marijuana uses (quantified as total sessions).
Data Analysis
Baseline Characteristics and Behavior. Group differences in age, IQ, education, drug use, and RGT behavior were compared in SPSS (version 24; IBM Corp., Armonk, NY) by independent-samples t tests, whereas differences in gender, race/ethnicity, and handedness were analyzed using chisquare tests (Table 1) . To evaluate whether follow-up status differed as a function of baseline preferred stimulant type (cocaine vs. prescription amphetamines) or in relation to the history of/presence of comorbid alcohol and marijuana abuse or dependence, chi-square analyses were performed.
Risky Gains Task. The RGT was analyzed in two stages.
First, decision contrasts evaluated differences between groups when individuals made a "risky" (640 or 680) versus "safe" (120) decision. All risky responses were combined to create a relatively even split between risky and safe decisions. Second, outcome contrasts evaluated differences in response after wins (140 and 180) versus losses (240 and 280) on risky trials; participants without five of each trial type (safe [20] vs. risky [40 or 80] ) were excluded from analysis. Neuroimaging. fMRI data were analyzed using Analysis of Functional Neuroimages software (62) . Single-subject data preprocessing procedures are outlined in Reske et al. (42) . Multiple regressor analysis and individual linear contrasts were computed in 3dDeconvolve, including six motion regressors as well as baseline and linear drift. Deconvolution was performed to examine the decision contrast (risky = 640 and 680; safe = 120) and outcome contrast (risky wins = 140 and 180; risky losses = 240 and 280). Voxels were resampled into 4 3 4 3 4-mm 3 space, and whole-brain voxelwise normalized percentage signal change, the main dependent measure, was determined by dividing the beta coefficient for each of the predictors of interest (BOLD signals for risky vs. safe decisions and risky wins vs. risky losses) by the beta coefficient for the BDI, Beck Depression Inventory; BIS-11, Barratt Impulsiveness Scale-Version 11; DSUs, desisted stimulant users; PSUs, problem stimulant users; SSS-V, Sensation-Seeking Scale-Form V.
a Determined by urine screen at the outset of the neuroimaging session. Individual subject values for risky decisions, safe decisions, risky win outcomes, and risky loss outcomes for each voxel included in a whole-brain mask were extracted for statistical analyses. Individual voxels meeting a p , .01 significance criterion as a result of statistical tests outlined below were evaluated further to determine whether they comprised a significant brain cluster after correction for multiple comparisons. In categorical analyses, for each voxel, a linear mixed effects model was performed in R (63) to identify significant regions of percentage signal change between PSUs and DSUs for decision and outcome analyses separately. Group was the between-subjects variable, and subject was a random variable. Within-subject variables were decision type (risky vs. safe) and outcome type (risky wins vs. risky losses). Cohen's d was calculated to determine effect sizes.
In dimensional analyses, multiple regressions were computed for each brain voxel, with two separate dependent variables: 1) percentage signal change for risky minus safe decisions and 2) percentage signal change for risky wins minus losses. Predictors in each regression were the following: 1) baseline stimulant uses, 2) interim stimulant uses, 3) baseline marijuana uses, and 4) interim marijuana uses. All predictors were log transformed due to nonnormality and Z-scored prior to regression entry.
In extracting significant whole-brain clusters, neuroimaging analysis software has been criticized for underestimating spatial autocorrelation, leading to insufficient multiple comparison corrections. In response to these concerns, 1) the updated 3dFWHMx program was employed to more reliably estimate true autocorrelation and smoothness present following blurring (5 mm) and 2) an updated version of 3dClustSim was run to account for autocorrelation given our voxel/whole-brain mask size, 10,000 Monte Carlo simulations and two-sided thresholding with an overall voxel p statistical threshold of .01 and a corrected clusterwise alpha value of .01. Data smoothness was approximately 6 mm, and . 19 neighboring voxels (or . 1216 mL) comprised a significant brain cluster.
RESULTS
Demographic and Behavioral Characteristics
Although groups did not differ in baseline stimulant use (Table 1) , PSUs used amphetamines more recently prior to the fMRI scan than DSUs. Groups did not differ on baseline or interim marijuana uses or on frequency of baseline/interim cannabis abuse or dependence diagnoses. DSUs endorsed higher depression scores than PSUs, although they were not clinically elevated. Preferred stimulant type at baseline was not related to follow-up group (Table 2) .
Although groups did not differ in frequency of type of trial chosen (20, 40, or 80) , rewarded/punished trials, or risky losses followed by a risky loss (Table 3) , PSUs made a greater number of risky decisions after a win than DSUs, while DSUs made more safe decisions following a win.
Neuroimaging: Categorical Analyses
For purposes of illustration, interaction effects are graphed as difference scores (Table 4) .
Decision Contrast. No group main effect emerged. The group by decision interaction indicated that PSUs exhibited greater cingulate and precuneus BOLD signals to risky decisions than to safe decisions when compared with DSUs ( Figure 3) .
Outcome Contrast. The group main effect demonstrated that across risky wins and losses, PSUs displayed weaker superior/middle frontal, cingulate, insula, striatum (putamen, lentiform nucleus), and posterior cingulate BOLD DSUs, desisted stimulant users; PSUs, problem stimulant users. (Figure 4) . The group by outcome interaction showed that PSUs exhibited greater thalamic, inferior/middle temporal, and occipital BOLD signals to win risky feedback than to lose risky feedback than DSUs ( Figure 5 ).
Neuroimaging: Dimensional Analyses
Higher interim marijuana use was linked to lower superior/ middle/inferior frontal, inferior parietal, superior/middle temporal, thalamus, and precuneus activation for risky decisions compared with safe decisions (Figure 6 ). No significant clusters emerged for baseline marijuana or baseline/interim stimulant uses (Table 5) .
DISCUSSION
This study employed categorical and dimensional analysis strategies in OSUs to determine whether baseline biobehavioral RGT responses predicted future stimulant use.
Categorical Analyses: PSUs Versus DSUs
Three hypotheses were tested. First, consistent with the prediction that PSUs would exhibit riskier task performance than DSUs, PSUs more frequently made a risky decision following a win compared with DSUs, while DSUs more frequently made a safe decision following a risky win. This pattern supports previous findings that PSUs are more reactive to rewards (28) . Second, although it was predicted that PSUs would show greater activation in reward processing striatal regions to risky wins than to risky losses when compared with DSUs, our results demonstrated the opposite effect, with PSUs exhibiting lower striatal BOLD signals across outcomes than DSUs. However, this finding is consistent with a longitudinal study of sensation-seeking adolescents in which striatal hypoactivation predicted future problematic drug use; the authors theorized that lower striatal activity may lead to a compensatory mechanism in which one seeks out increased risk to gain greater stimulation, thereby balancing reward center hypoactivation (44).
PSUs exhibited greater temporo-occipital BOLD signals to wins than to losses, findings consistent with a recent meta-analysis reporting that 86% of addiction-related neuroimaging studies demonstrate significant visual cortex activity to drug cues (64) . Although the RGT did not test drug-related responses, our results demonstrate an analogous relationship to general reward cues, suggesting that PSUs may allocate greater visual attention to risky rewards than to risky losses. Middle temporal lobe is involved in memory of reward-based information critical for futureoriented decision making, suggesting that PSUs may be less able to consolidate information about outcomes differently (65) . Together, PSUs are characterized by visual attention and memory activation during risky rewards but blunted responsivity to loss outcomes.
Our third prediction was supported in that PSUs exhibited lower PFC, insula, and cingulate BOLD signals than DSUs web 4C=FPO during risky feedback. These findings align with a recent study conducted by our research group demonstrating that during a task evaluating how individuals learn to make decisions, PSUs exhibited lower insula and ACC activation across all available outcomes (wins, losses, and ties) than DSUs (66) . Such patterns are consistent with previous reports of PFC, insula, and ACC attenuations in chronic stimulant users that are linked with decreased ability to adapt behavior using prior experiences/ reduced inhibitory control, interoceptive awareness, and conflict monitoring, respectively (34) (35) (36) 52) . Thus, young adults predisposed to SUD may have prior deficits in recruiting neural effort toward critical decision-making processes. Nonhypothesized group differences also emerged in thalamic, precuneus, and posterior cingulate regions that warrant discussion. PSUs showed relatively greater precuneus and posterior cingulate BOLD signals when making risky decisions than when making safe decisions when compared with DSUs. Such differences are consistent with previous findings in SUD samples that heightened activation of these areas during exteroceptive awareness (evaluative processing of external stimuli) may underlie the maintenance and exacerbation of substance use (67) . Greater thalamic response to risky reward versus loss feedback in PSUs is consistent with research demonstrating that thalamic BOLD signals are linked to relapse in cocaine-dependent individuals (68) . Thalamus acts as a relay center for the brain by sending sensory information to insula for further interoceptive processing (32); hypoactivation to loss may reflect differences in relay and integration of information during decision making.
With respect to baseline characteristics, DSUs endorsed higher baseline levels of state depression than PSUs, which may have affected RGT performance given that individuals with depression tend to be risk averse (69) . However, given that mean scores for DSUs are substantially below the Beck Depression Inventory threshold for clinical depression [in nonclinical populations, scores above 20 indicate depression (70); it is unlikely that DSUs performed in a manner consistent with samples with depression].
Dimensional Analyses: Interim Marijuana Use
Across OSUs, lower frontal, temporal, parietal, insular, and thalamic BOLD signals during risky decisions compared with safe decisions predicted greater future marijuana use (when accounting for baseline/future stimulant use and baseline marijuana use). These regions are considered important for executive functions such as inhibitory control, working memory, and attention as well as for being relay centers for integrating information critical for decision making (17, 18, 32, 71) . Therefore, blunted responses in these regions while making choices between risky and safe options may predispose young adults to repeatedly choose marijuana consumption despite potential negative consequences (72) . While cumulative marijuana uses (i.e., defined as a continuous variable) between study visits was related to baseline BOLD patterns, lack of relationship between cumulative interim stimulant use and baseline BOLD signal suggests that while a web 4C=FPO Figure 6 . Interim marijuana use predicting blood oxygen level-dependent signals for risky minus safe decisions. Higher interim marijuana use was linked to lower superior/middle/inferior frontal gyri, inferior parietal lobule, superior/middle temporal gyri, thalamus, and precuneus activation for risky decisions compared with safe decisions at baseline. dose-response effect may exist between brain activation and marijuana use, the relationship between brain activation and stimulant use may be better defined through a categorical perspective that includes accompanying clinical symptomology. Although PSUs and DSUs used marijuana at significantly high rates (range = 0-17,046 sessions), groups did not differ categorically in marijuana abuse/dependence frequency. In contrast, stimulant use in and of itself (range = 3-4862 sessions) might not be related to brain differences unless it is accompanied by clinical problems, suggesting that a categorical perspective is a more useful way to conceptualize differences.
Study Design: Strengths and Weaknesses
This study has several unique strengths, including its longitudinal design, use of a model previously applied to chronic stimulant users, and assessment of substance use from both categorical and dimensional perspectives (58) . However, this study is limited by our sample's significant co-use of marijuana and the categorical criteria that prioritized differences as a function of SUD over marijuana use disorder given that PSUs and DSUs did not differ on baseline/interim marijuana use. In addition, although SUD has been associated with greater incidence of psychiatric illness (73, 74) , lack of clinical symptom measures collected at follow-up hinders our ability to determine whether mental health symptoms affected interim substance use. We are also limited by an inability to evaluate the RGT from a trialby-trial perspective to determine whether BOLD response patterns translate into future behavior or are affected by the preceding trial; due to the limited number of separate 40
and 80 trials, it would not be possible to obtain sufficient statistical power to conduct such an analysis.
Conclusions and Future Directions
Preexisting BOLD signal patterns during risky decision making predict transition to SUD. Frontocingulate, insular, and striatal blunting to feedback after selection of a risky choice may predispose young adults to future decision-making impairments (continuing to use stimulants despite clinical problems). Moreover, blunted frontal, insular, and striatal BOLD signals during action selection predict greater frequency of future marijuana use. Future research is needed to determine whether these biomarkers can identify at-risk individuals who might benefit from targeted interventions. 
